SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells

Sungguan Hong, Hyangsoon Noh, Yong Teng, Jing Shao, Hina Rehmani, Hanfei Ding, Zheng Dong, Shi Bing Su, Huidong Shi, Jaejik Kim, Shuang Huang

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

MicroRNAs have added a new dimension to our understanding of tumorigenesis and associated processes like epithelial-to-mesenchymal transition (EMT). Here, we show that miR-375 is elevated in epithelial-like breast cancer cells, and ectopic miR-375 expression suppresses EMT in mesenchymal-like breast cancer cells. We identified short stature homeobox 2 (SHOX2) as a miR-375 target, and miR-375-mediated suppression in EMT was reversed by forced SHOX2 expression. Ectopic SHOX2 expression can induce EMT in epithelial-like breast cancer cells, whereas SHOX2 knockdown diminishes EMT traits in mesenchymal-like breast cancer cells, demonstrating SHOX2 as an EMT inducer. We show that SHOX2 acts as a transcription factor to upregulate transforming growth factor β receptor I (TβR-I) expression, and TβR-I inhibitor LY364947 abolishes EMT elicited by ectopic SHOX2 expression, suggesting that transforming growth factor β signaling is essential for SHOX2-induced EMT. Manipulating SHOX2 abundance in breast cancer cells impact in vitro invasion and in vivo dissemination. Analysis of breast tumor microarray database revealed that high SHOX2 expression significantly correlates with poor patient survival. Our study supports a critical role of SHOX2 in breast tumorigenicity.

Original languageEnglish (US)
Pages (from-to)279-290.e5
JournalNeoplasia (United States)
Volume16
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Epithelial-Mesenchymal Transition
Homeobox Genes
Breast Neoplasms
Transforming Growth Factors
Growth Factor Receptors
MicroRNAs
Carcinogenesis
Breast
Transcription Factors
Up-Regulation
Databases

ASJC Scopus subject areas

  • Cancer Research

Cite this

SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells. / Hong, Sungguan; Noh, Hyangsoon; Teng, Yong; Shao, Jing; Rehmani, Hina; Ding, Hanfei; Dong, Zheng; Su, Shi Bing; Shi, Huidong; Kim, Jaejik; Huang, Shuang.

In: Neoplasia (United States), Vol. 16, No. 4, 01.01.2014, p. 279-290.e5.

Research output: Contribution to journalArticle

Hong, Sungguan ; Noh, Hyangsoon ; Teng, Yong ; Shao, Jing ; Rehmani, Hina ; Ding, Hanfei ; Dong, Zheng ; Su, Shi Bing ; Shi, Huidong ; Kim, Jaejik ; Huang, Shuang. / SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells. In: Neoplasia (United States). 2014 ; Vol. 16, No. 4. pp. 279-290.e5.
@article{1bbe49e2fe8d42858acc587a72b1a3d2,
title = "SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells",
abstract = "MicroRNAs have added a new dimension to our understanding of tumorigenesis and associated processes like epithelial-to-mesenchymal transition (EMT). Here, we show that miR-375 is elevated in epithelial-like breast cancer cells, and ectopic miR-375 expression suppresses EMT in mesenchymal-like breast cancer cells. We identified short stature homeobox 2 (SHOX2) as a miR-375 target, and miR-375-mediated suppression in EMT was reversed by forced SHOX2 expression. Ectopic SHOX2 expression can induce EMT in epithelial-like breast cancer cells, whereas SHOX2 knockdown diminishes EMT traits in mesenchymal-like breast cancer cells, demonstrating SHOX2 as an EMT inducer. We show that SHOX2 acts as a transcription factor to upregulate transforming growth factor β receptor I (TβR-I) expression, and TβR-I inhibitor LY364947 abolishes EMT elicited by ectopic SHOX2 expression, suggesting that transforming growth factor β signaling is essential for SHOX2-induced EMT. Manipulating SHOX2 abundance in breast cancer cells impact in vitro invasion and in vivo dissemination. Analysis of breast tumor microarray database revealed that high SHOX2 expression significantly correlates with poor patient survival. Our study supports a critical role of SHOX2 in breast tumorigenicity.",
author = "Sungguan Hong and Hyangsoon Noh and Yong Teng and Jing Shao and Hina Rehmani and Hanfei Ding and Zheng Dong and Su, {Shi Bing} and Huidong Shi and Jaejik Kim and Shuang Huang",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.neo.2014.03.010",
language = "English (US)",
volume = "16",
pages = "279--290.e5",
journal = "Neoplasia (United States)",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells

AU - Hong, Sungguan

AU - Noh, Hyangsoon

AU - Teng, Yong

AU - Shao, Jing

AU - Rehmani, Hina

AU - Ding, Hanfei

AU - Dong, Zheng

AU - Su, Shi Bing

AU - Shi, Huidong

AU - Kim, Jaejik

AU - Huang, Shuang

PY - 2014/1/1

Y1 - 2014/1/1

N2 - MicroRNAs have added a new dimension to our understanding of tumorigenesis and associated processes like epithelial-to-mesenchymal transition (EMT). Here, we show that miR-375 is elevated in epithelial-like breast cancer cells, and ectopic miR-375 expression suppresses EMT in mesenchymal-like breast cancer cells. We identified short stature homeobox 2 (SHOX2) as a miR-375 target, and miR-375-mediated suppression in EMT was reversed by forced SHOX2 expression. Ectopic SHOX2 expression can induce EMT in epithelial-like breast cancer cells, whereas SHOX2 knockdown diminishes EMT traits in mesenchymal-like breast cancer cells, demonstrating SHOX2 as an EMT inducer. We show that SHOX2 acts as a transcription factor to upregulate transforming growth factor β receptor I (TβR-I) expression, and TβR-I inhibitor LY364947 abolishes EMT elicited by ectopic SHOX2 expression, suggesting that transforming growth factor β signaling is essential for SHOX2-induced EMT. Manipulating SHOX2 abundance in breast cancer cells impact in vitro invasion and in vivo dissemination. Analysis of breast tumor microarray database revealed that high SHOX2 expression significantly correlates with poor patient survival. Our study supports a critical role of SHOX2 in breast tumorigenicity.

AB - MicroRNAs have added a new dimension to our understanding of tumorigenesis and associated processes like epithelial-to-mesenchymal transition (EMT). Here, we show that miR-375 is elevated in epithelial-like breast cancer cells, and ectopic miR-375 expression suppresses EMT in mesenchymal-like breast cancer cells. We identified short stature homeobox 2 (SHOX2) as a miR-375 target, and miR-375-mediated suppression in EMT was reversed by forced SHOX2 expression. Ectopic SHOX2 expression can induce EMT in epithelial-like breast cancer cells, whereas SHOX2 knockdown diminishes EMT traits in mesenchymal-like breast cancer cells, demonstrating SHOX2 as an EMT inducer. We show that SHOX2 acts as a transcription factor to upregulate transforming growth factor β receptor I (TβR-I) expression, and TβR-I inhibitor LY364947 abolishes EMT elicited by ectopic SHOX2 expression, suggesting that transforming growth factor β signaling is essential for SHOX2-induced EMT. Manipulating SHOX2 abundance in breast cancer cells impact in vitro invasion and in vivo dissemination. Analysis of breast tumor microarray database revealed that high SHOX2 expression significantly correlates with poor patient survival. Our study supports a critical role of SHOX2 in breast tumorigenicity.

UR - http://www.scopus.com/inward/record.url?scp=84903964215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903964215&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2014.03.010

DO - 10.1016/j.neo.2014.03.010

M3 - Article

C2 - 24746361

AN - SCOPUS:84903964215

VL - 16

SP - 279-290.e5

JO - Neoplasia (United States)

JF - Neoplasia (United States)

SN - 1522-8002

IS - 4

ER -